The reversal off the low from June is a good guide. It

New Post Public Reply Private Reply Replies (2) Message Board
coolnapz allbetson #3145

The reversal off the low from June is a good guide. It shares a lot of things on the chart with where we are now but lets focus on a few things. First was that on June 27th the stock dropped from 3 cents to just above 2.5 cents and closed at the lows. The following day, June 28th, it opened at the lows, price pierced as low as 2.2 cents, but then it closed off of the lows at 2.8 cents.

That day marked a reversal and then boom went the stock.

http://investorshangout.com/post/view?id=1876...post_name=

The 10 K was released on June 13th. The 10 Q was released on June 25th. The stock still went down. If you check Facebook you will see that there was a piece of news on June 28th, but it was about Madley being permitted. I don't believe that was the catalyst because there was a permit approval for McComas on the 21st. None of the news releases around this time either gave us increase production news.

What I think happened are two things. First, 2.5 cents was a very strong level of support. Second, the market had a delayed reaction to the news, specifically the financials. People on this board might be ready to buy another 100,000 shares 5 minutes after the financials come out but once again, we are the loyal shoppers and that's not what's going to move the stock.

We just got financials and yet once again we see a few days later we are trading down on an intraday basis and so far not seeing a pop. The rest of the market needs a chance to get wind of the financials, digest it, assess risk reward, and then pull the trigger. Don't count on that happening tomorrow because it is Turkey day, or Friday because most people are going to take a long weekend. So, that is why I am looking to next week.

I think it takes a few days to get a reaction to the financials just like last time. Last time revenue was about 15K, this time it was 75K with other financial highlights. Given that 2 cents is worst case downside that is only a 33% loss and justifies a 3 cent buy without even thinking for a chance at 7 cents.

This should generate enough action to get us a close above the 50 day moving average which is only 3.3 cents. A close above the 50 DMA is a major trigger that upon occurring can get us to 4.5 cents the following day. That is why the bears fought so hard to stuff that print but there is a big difference in trying to stuff 3.5 cents and trying to stuff 3.3 cents when as I mentioned above, 2 cents is worst case with a 33% loss and you have short term guys eying a run to 7 cents. Honestly, there are some traders who will look at this and say 2.5 cents is their worst case and still eye 7 cents on the upside for a quick flip.

I am looking at an 80% chance of this happening next week, with a 70% chance of the week after. This is based on the trade pattern seen on the reversal off of the 2.5 cent hit in late June. If it doesn't occur in that stated time frame then it expires because last time it didn't take 2-3 weeks or for that matter greater for the pattern to play out.

If that is the case then I will just have to watch the higher low pattern continue to develop and watch for that close above the 50 day moving average, which is going to be the trigger for this rally whether it hits on this pattern I identified for next week, or for the longer term pattern.

Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 31

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 31

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breast Suite Transforming Cancer Detection and Care

Updated Category News Views 118

Introducing the AI-Driven DeepHealth Breast Suite DeepHealth has recently launched its Breast Suite, a revolutionary set of AI-powered applications that significantly boosts the effectiveness of breast cancer detection and patient care. This suite is part of a broader initiative to improve health informatics and operational efficiency, showcasing DeepHealth's commitment...

Continue Reading
AVATR Unveils Innovative Luxury Electric Vehicle in Munich

Updated Category News Views 193

AVATR Unveils Innovative Luxury Electric Vehicle in Munich At the recent "Brilliant New Horizon AVATR Brand Day" event, the President of AVATR Technology, Mr. Chen Zhuo, shared insights about the brand's identity. He explained that AVATR transcends the typical electric vehicle company image by embracing high-end sophistication, intelligence, and design. Emotional...

Continue Reading
Security Federal Corporation Expands Stock Repurchase Program

Updated Category News Views 128

Security Federal Corporation Unveils New Stock Repurchase Program Security Federal Corporation (the “Company”) (OTCBB: SFDL), which serves as the holding company for Security Federal Bank (the “Bank”), has recently announced an increase in the number of shares it is authorized to repurchase under its existing stock repurchase program. This updated initiative...

Continue Reading
Experience 'Hot Fellas' Bakery: Immersive NYC Event Awaits

Updated Category News Views 379

Unveiling the Hot Fellas Bakery Pop-Up Experience in NYC The beloved storyline of the Max Original series "And Just Like That…" springs to life with an exciting two-day immersive pop-up event. Fans will have the unique opportunity to step into Anthony Marentino's famous 'Hot Fellas' Bakery, inviting them to participate in a fun and delicious experience. Details of the...

Continue Reading
EyePoint Pharmaceuticals Pursues Major Stock Offering for Growth

Updated Category News Views 228

EyePoint Pharmaceuticals Pursues Major Stock Offering EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leader in developing innovative therapies for patients suffering from serious retinal diseases, has taken a significant step toward advancing its initiatives by announcing a proposed underwritten public offering. The company is set to offer $150 million of its common...

Continue Reading